作者：
Hana,Sarashina-Kida [1]
;
Hideo,Negishi [2]
;
Junko,Nishio [1]
;
Wataru,Suda [1]
;
Yuki,Nakajima [3]
;
Mika,Yasui-Kato [4]
;
Keiko,Iwaisako [5]
;
Sujin,Kang [1]
;
Nobuyasu,Endo [1]
;
Hideyuki,Yanai [6]
;
Masataka,Asagiri [2]
;
Hiroshi,Kida [7]
;
Masahira,Hattori [1]
;
Atsushi,Kumanogoh [1]
;
Tadatsugu,Taniguchi [8]
作者单位：
Department of Molecular Immunology, Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan.
[1]
Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.
[2]
Laboratory for Microbiome Sciences, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.
[3]
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo 160-8582, Japan.
[4]
Laboratory of Metagenomics, Department of Computational Biology and Medical Science, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba 277-8561, Japan.
[5]
Department of Target Therapy Oncology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
[6]
Department of Immune Regulation, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
[7]
Max Planck-The University of Tokyo Center for Integrative Inflammology, Tokyo 153-8505, Japan.
[8]
Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 467-8603, Japan.
[9]
Graduate School of Advanced Science and Engineering, Waseda University, Tokyo 169-8555, Japan.
[10]
Department of Molecular Immunology, Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan; tada-t@iis.u-tokyo.ac.jp.
[11]
DOI
10.1073/pnas.1712837114
PMID
28878025
发布时间
2022-03-18
换一批
换一批
